A Study of IMC-A12 in Advanced Solid Tumors
Clinical trial NCT01007032 · COMPLETED
Trial details
- NCT number
- NCT01007032
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-12-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.